Astec Lifesciences Share Price
28 Oct, 2026 3:31 PM (IST)
Astec Lifesciences Performance
- Today's Low
- ₹596
- Today's High
- ₹664
- 52 Week Low
- ₹513
- 52 Week High
- ₹942
- Open Price₹645
- Previous Close₹644
- Volume117,699
- 50 DMA₹680.80
- 100 DMA₹678.70
- 200 DMA₹691.30
Astec Lifesciences Chart
Investment Returns
- Over 1 Month -18.41%
- Over 3 Month -9.28%
- Over 6 Month -19.6%
- Over 1 Year -8.62%
Smart Investing Starts Here Start SIP with Astec Lifesciences for Steady Growth!
Astec Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -16.9
- PEG Ratio
- -0.6
- Market Cap Cr
- 1,344
- P/B Ratio
- 3.6
- Average True Range
- 43.6
- EPS
- -35.7
- Dividend Yield
- 0
- MACD Signal
- -13.4
- RSI
- 32.94
- MFI
- 23.1
Latest Stock News Updates
Please find enclosed, newspaper publication of Financial Results for the Quarter and Half Year ended September 30, 2026.
- BSE India
- 1 day 15 hours ago
Please find attached Press Release
- BSE India
- 2 days 7 hours ago
<h3><span style="font-size:16px;"><strong>Agrochemicals company Astec Lifesciences announced Q2FY27 results</strong></span></h3> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,null,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICRAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gA2uv_1c"> <li data-complete="true" data-hveid="CAAICRAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_1f">Revenue from Operations<!--TgQPHd|||[]--></strong> stood at Rs 7,202.01 lakh in Q2FY27, recording a YoY decrease of 2.31% from Rs 7,372.06 lakh in Q2FY26 and a sequential decline of 13.81% compared to Rs 8,356.43 lakh in Q1FY27. For H1FY27, standalone revenue from operations reached Rs 15,558.44 lakh, marking a 5.59% drop from Rs 16,480.27 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_1t"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_1v">Total Income<!--TgQPHd|||[]--></strong> stood at Rs 7,261.73 lakh in Q2FY27, registering a contraction of 2.94% YoY over Rs 7,481.50 lakh in Q2FY26 and dropping 13.83% QoQ relative to Rs 8,427.28 lakh in Q1FY27. For H1FY27, standalone total income reached Rs 15,689.01 lakh, sliding 5.71% YoY from Rs 16,638.37 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_21"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_23">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong> (reported as Loss Before Tax) landed at a negative Rs 3,746.96 lakh in Q2FY27, widening significantly from a loss of Rs 2,445.09 lakh in Q2FY26 (a 53.24% loss expansion YoY) and expanding by 99.53% QoQ against a loss of Rs 1,877.92 lakh in Q1FY27. Standalone H1FY27 loss before tax was established at Rs 5,624.88 lakh, down 2.18% over a loss of Rs 5,750.73 lakh noted in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_29"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2b">Profit After Tax (PAT)<!--TgQPHd|||[]--></strong> (reported as Loss For the Period) recorded a negative Rs 3,742.88 lakh in Q2FY27, widening by 53.07% YoY over a loss of Rs 2,445.09 lakh in Q2FY26 and expanding by 99.74% sequentially against a loss of Rs 1,873.84 lakh in Q1FY27. Standalone H1FY27 loss after tax came in at Rs 5,616.72 lakh, showing a small compression of 2.33% over a loss of Rs 5,750.73 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAQ" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2h"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2j">Earnings Per Share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted arrived at a negative Rs 16.80 in Q2FY27, representing a 47.50% loss increase YoY from a negative Rs 11.39 in Q2FY26 and a 99.76% loss expansion sequentially over a negative Rs 8.41 in Q1FY27. For H1FY27, basic and diluted standalone EPS came in at a negative Rs 25.21, narrowing its loss framework by 9.93% against a negative Rs 27.99 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,null,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICxAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gA2uv_2r"> <li data-complete="true" data-hveid="CAAICxAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2s"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2u">Revenue From Operations<!--TgQPHd|||[]--></strong> stood at Rs 7,202.01 lakh in Q2FY27, tracking a YoY reduction of 2.31% over Rs 7,372.06 lakh in Q2FY26 alongside a QoQ drop of 13.81% from Rs 8,356.43 lakh in Q1FY27. For H1FY27, consolidated revenue from operations aggregated to Rs 15,558.44 lakh, descending by 5.59% relative to Rs 16,480.27 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2y"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_30">Total Income<!--TgQPHd|||[]--></strong> arrived at Rs 7,263.64 lakh in Q2FY27, representing a YoY slip of 2.94% from Rs 7,483.62 lakh in Q2FY26 and tracking an 13.83% sequential fall from Rs 8,429.17 lakh in Q1FY27. Consolidated total income for H1FY27 reached Rs 15,692.81 lakh, decreasing by 5.71% YoY over Rs 16,642.48 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_31"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_33">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong> (reported as Loss Before Tax) landed at a negative Rs 3,742.78 lakh in Q2FY27, widening by 53.35% YoY relative to a loss of Rs 2,440.74 lakh in Q2FY26 and expanding by 99.74% QoQ against a loss of Rs 1,873.82 lakh in Q1FY27. Consolidated H1FY27 loss before tax was posted at Rs 5,616.60 lakh, narrowing by 2.19% YoY compared to a loss of Rs 5,742.49 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_34"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_36">Profit After Tax (PAT)<!--TgQPHd|||[]--></strong> (reported as Loss For the Period) came in at a negative Rs 3,739.71 lakh in Q2FY27, expanding its loss position by 53.16% YoY from a loss of Rs 2,441.70 lakh in Q2FY26 and scaling up by 99.91% QoQ compared to a loss of Rs 1,870.73 lakh in Q1FY27. Consolidated H1FY27 loss after tax logged Rs 5,610.44 lakh, decreasing by 2.33% YoY relative to a loss of Rs 5,744.39 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAG" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_37"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_39">Earnings Per Share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted was established at a negative Rs 16.79 in Q2FY27, representing a 47.93% loss expansion YoY over a negative Rs 11.35 in Q2FY26 and a 99.88% loss spike sequentially over a negative Rs 8.40 in Q1FY27. For H1FY27, basic and diluted consolidated EPS arrived at a negative Rs 25.19, reflecting a 9.94% loss reduction versus a negative Rs 27.97 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5910662/" target="_blank">Result PDF</a></p>
- Trendlyne
- 2 days 8 hours ago
Astec Lifesciences Financials
Astec Lifesciences Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹682.00
- 50 Day
- ₹680.80
- 100 Day
- ₹678.70
- 200 Day
- ₹691.30
Resistance and Support
- R3 713.50
- R2 688.50
- R1 645.70
- S1 577.90
- S2 552.90
- S3 510.10
Astec Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-10-26 | Quarterly Results | |
| 2026-07-31 | Quarterly Results | |
| 2026-04-27 | Audited Results | |
| 2026-01-30 | Quarterly Results | |
| 2025-10-29 | Quarterly Results |
About Astec Lifesciences
Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. View More- NSE Symbol
- ASTEC
- BSE Symbol
- 533138
- ISIN
- INE563J01010
Similar Stocks to Astec Lifesciences
Popular Stocks
Astec Lifesciences FAQs
Astec Lifesciences share price is ₹602 As on 29 October, 2026 | 02:05
The Market Cap of Astec Lifesciences is ₹1343.5 Cr As on 29 October, 2026 | 02:05
The P/E ratio of Astec Lifesciences is -16.9 As on 29 October, 2026 | 02:05
The PB ratio of Astec Lifesciences is 3.6 As on 29 October, 2026 | 02:05
The 52 week High & Low of Astec Lifesciences is ₹941.8/₹513.4 respectively As on 29 October, 2026 | 02:05
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.